Compounds > berotek
Page last updated: 2024-10-27

berotek and Coronary Disease

berotek has been researched along with Coronary Disease in 2 studies

Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Irmer, M1
Wollschläger, H1
Just, H1
Klusova, EV1
Semenovich, NI1
Polivanov, EG1
Pashkova, TL1

Trials

1 trial available for berotek and Coronary Disease

ArticleYear
[Berotek treatment of bronchial asthma in combination with ischemic heart disease].
    Sovetskaia meditsina, 1979, Issue:4

    Topics: Adult; Age Factors; Aged; Asthma; Bronchial Spasm; Chronic Disease; Clinical Trials as Topic; Corona

1979

Other Studies

1 other study available for berotek and Coronary Disease

ArticleYear
[Treatment of severe congestive heart failure with the beta-agonist fenoterol (author's transl)].
    Klinische Wochenschrift, 1981, Jun-15, Volume: 59, Issue:12

    Topics: Adrenergic beta-Agonists; Adult; Aged; Cardiac Output, Low; Coronary Disease; Ethanolamines; Female;

1981